JÉRÔME GEMBERLING, MÉDECINE GÉNÉRALE
0848.092.378 · rovalta.com · 26/09/2026
ACTIVE
JÉRÔME GEMBERLING, MÉDECINE GÉNÉRALE
Financial year 2025 · Closed on 31/12/2025
Net result132,7 k €-6,0 %over 1 year
Gross margin218,2 k €-2,2 %over 1 year
Equity411,3 k €-25,0 %over 1 year
Overview
Identity
Source · BCE/KBOJÉRÔME GEMBERLING, MÉDECINE GÉNÉRALE is a Private limited company incorporated in 2012. Its registered office is in Namur.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0848.092.378
- Incorporation
- 20/08/2012
- Legal form
- Private limited company
- Registered office
- Rue de Monin(WP) 2
5100 Namur · WallonieSee on map - Contributed capital
- 100,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 14 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 218,2 k € | -2.2% | 223,1 k € | -4.5% | 233,7 k € | +2.9% | 227,2 k € | +9.0% | 208,4 k € |
| EBITDA | 215,4 k € | -2.3% | 220,4 k € | -4.6% | 231,1 k € | +3.5% | 223,3 k € | +8.2% | 206,4 k € |
| Operating result | 192,1 k € | -3.8% | 199,7 k € | -6.3% | 213,2 k € | +7.3% | 198,6 k € | +8.8% | 182,6 k € |
| Net result | 132,7 k € | -6.0% | 141,1 k € | -6.2% | 150,5 k € | +8.8% | 138,3 k € | +8.8% | 127,1 k € |
| Balance sheet | |||||||||
| Equity | 411,3 k € | -25.0% | 548,6 k € | +7.8% | 509 k € | +16.3% | 437,5 k € | +16.8% | 374,5 k € |
| Total assets | 817,4 k € | +2.6% | 796,6 k € | +7.1% | 743,9 k € | +13.7% | 654 k € | +17.7% | 555,9 k € |
| Cash | 279,2 k € | +8.8% | 256,6 k € | -21.0% | 324,8 k € | +46.2% | 222,2 k € | +31.0% | 169,6 k € |
| Debts | 406,1 k € | +63.8% | 247,9 k € | +5.5% | 234,9 k € | +8.5% | 216,5 k € | +19.4% | 181,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Jérôme GEMBERLING
ActiveEnded mandates
Jérôme GEMBERLING
EndedJérôme GEMBERLING
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2026 | 28/05/2025 | 18/06/2024 | 03/07/2023 | 05/08/2022 | 29/07/2021 |
| General meeting | 27/03/2026 | 02/05/2025 | 03/05/2024 | 05/05/2023 | 06/05/2022 | 20/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 27/03/2026 | 23/06/2026 | French | |
| Micro model | 31/12/2024 | 02/05/2025 | 28/05/2025 | French | |
| Micro model | 31/12/2023 | 03/05/2024 | 18/06/2024 | French | |
| Micro model | 31/12/2022 | 05/05/2023 | 03/07/2023 | French | |
| Micro model | 31/12/2021 | 06/05/2022 | 05/08/2022 | French | |
| Micro model | 31/12/2020 | 20/03/2021 | 29/07/2021 | French | |
| Micro model | 31/12/2019 | 17/03/2020 | 04/08/2020 | French | |
| Micro model | 31/12/2018 | 19/03/2019 | 14/08/2019 | French | |
| Micro model | 31/12/2017 | 20/03/2018 | 29/08/2018 | French | |
| Micro model | 31/12/2016 | 21/03/2017 | 04/07/2017 | French | |
| Abridged model | 31/12/2015 | 15/03/2016 | 31/08/2016 | French | |
| Abridged model | 31/12/2014 | 17/03/2015 | 29/08/2015 | French | |
| Abridged modelCorrection | 31/12/2013 | 18/03/2014 | 11/09/2014 | French | |
| Abridged model | 31/12/2013 | 18/03/2014 | 29/08/2014 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Jérôme GEMBERLING
ActiveEnded mandates
Jérôme GEMBERLING
EndedJérôme GEMBERLING
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates15/03/2021MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
- Registered office17/04/2020SIEGE SOCIAL - MODIFICATION FORME JURIDIQUE
- Capital / shares10/01/2018CAPITAL, ACTIONS
- Registered office22/05/2015SIEGE SOCIAL
- Other29/08/2012RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025132,7 k €↓
- 2024Annual accounts 2024141,1 k €↓
- 2023Annual accounts 2023150,5 k €↑
- 2022Annual accounts 2022138,3 k €↑
- 2021Annual accounts 2021127,1 k €↑
- 2020Annual accounts 2020104,3 k €↑
- 2019Annual accounts 201960,3 k €↑
- 2018Annual accounts 201840,8 k €↑
- 2017Annual accounts 201720,2 k €↑
- 2016Annual accounts 201612,8 k €↑
- 2015Annual accounts 20151,9 k €↓
- 2014Annual accounts 201425,4 k €↑
- 2013Annual accounts 201322,4 k €
- 20/08/2012IncorporationPrivate limited company